JPS6341888B2 - - Google Patents

Info

Publication number
JPS6341888B2
JPS6341888B2 JP54101210A JP10121079A JPS6341888B2 JP S6341888 B2 JPS6341888 B2 JP S6341888B2 JP 54101210 A JP54101210 A JP 54101210A JP 10121079 A JP10121079 A JP 10121079A JP S6341888 B2 JPS6341888 B2 JP S6341888B2
Authority
JP
Japan
Prior art keywords
patients
immune function
decline
dialysis
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP54101210A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5626819A (en
Inventor
Tadao Aoki
Hideo Myakoshi
Yoshihei Hirasawa
Yasuho Nishii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Priority to JP10121079A priority Critical patent/JPS5626819A/ja
Priority to US06/176,641 priority patent/US4340604A/en
Publication of JPS5626819A publication Critical patent/JPS5626819A/ja
Publication of JPS6341888B2 publication Critical patent/JPS6341888B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP10121079A 1979-08-10 1979-08-10 Preventive for hypoimmunity Granted JPS5626819A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP10121079A JPS5626819A (en) 1979-08-10 1979-08-10 Preventive for hypoimmunity
US06/176,641 US4340604A (en) 1979-08-10 1980-08-11 Method for inhibiting the lowering of immunological function and agent therefor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10121079A JPS5626819A (en) 1979-08-10 1979-08-10 Preventive for hypoimmunity

Publications (2)

Publication Number Publication Date
JPS5626819A JPS5626819A (en) 1981-03-16
JPS6341888B2 true JPS6341888B2 (enExample) 1988-08-19

Family

ID=14294548

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10121079A Granted JPS5626819A (en) 1979-08-10 1979-08-10 Preventive for hypoimmunity

Country Status (2)

Country Link
US (1) US4340604A (enExample)
JP (1) JPS5626819A (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6045516A (ja) * 1983-08-02 1985-03-12 Kureha Chem Ind Co Ltd １α―ヒドロキシビタミンＤ３類を含有することを特徴とする抗炎症解熱鎮痛剤
US4749710A (en) * 1985-05-01 1988-06-07 Hoffmann-La Roche Inc. Immunosuppressive agents
US4997824A (en) * 1987-07-22 1991-03-05 Teva Pharmaceutical Industries Ltd. Combination of cholecalciferol derivatives for the treatment of renal bone disease
US6291444B1 (en) 1993-06-16 2001-09-18 Wisconsin Alumni Research Foundation Treatment of t-cell immunodeficiencies with vitamin D compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3741996A (en) * 1971-12-02 1973-06-26 Wisconsin Alumni Res Found 1{60 -hydroxycholecalciferol
JPS603045B2 (ja) * 1976-04-19 1985-01-25 中外製薬株式会社 １α―ヒドロキシビタミンＤ類軟カプセルの製造方法
US4225525A (en) * 1979-02-08 1980-09-30 Hoffmann-La Roche Inc. Vitamin D3 metabolite derivatives

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ACTA POEDIAT SCAND=1970 *
ACTA POEDIAT SCAND=1976 *

Also Published As

Publication number Publication date
US4340604A (en) 1982-07-20
JPS5626819A (en) 1981-03-16

Similar Documents

Publication Publication Date Title
Craft Torsade de pointes after astemizole overdose
Jaques et al. Intrapulmonary heparin: A new procedure for anticoagulant therapy
Singer et al. Risks and benefits of home parenteral nutrition in the acquired immunodeficiency syndrome
Barr et al. Oral prostaglandins in the induction of labour
McCurdy Chloramphenicol bone marrow toxicity
Nilsson et al. Charcoal hemoperfusion for treatment of serious carbamazepine poisoning
Wang et al. Calcium–Polystyrene Sulfonate Decreases Inter‐Dialytic Hyperkalemia in Patients Undergoing Maintenance Hemodialysis: A Prospective, Randomized, Crossover Study
Kulig et al. Levothyroxine overdose associated with seizures in a young child
JPS6341888B2 (enExample)
Albertson et al. A case of fatal sodium azide ingestion
Harrison et al. Bolus corticosteroids and cyclophosphamide for initial treatment of Wegener's granulomatosis
Lansing et al. Angina during hemodialysis: treatment by coronary bypass graft
Kelbaek et al. Effects of autonomic blockade on cardiac function at rest and during upright exercise in humans
SHANNON et al. Exchange transfusion in the treatment of severe theophylline poisoning
Safar et al. Central haemodynamics and plasma prostaglandin E2 in borderline and sustained essential hypertensive patients before and after indomethacin
Samii et al. Hemodynamic effects of dopamine in septic shock with and without acute renal failure
Gosselin et al. Acute intoxication with diisopyramide: clinical and experimental study by hemoperfusion on amberlite XAD 4 resin
BERLINGER et al. Hemoperfusion for phenylbutazone poisoning
Schaap et al. Massive pleural effusion attributed to high-dose cyclophosphamide during conditioning for BMT
Sperryn et al. Double-blind comparison of aspirin and 4-(acetamido) phenyl-2-acetoxy-benzoate (benorylate) in rheumatoid arthritis
Rubinger et al. Inefficiency of haemodialysis in acute phenytoin intoxication
Williams Blood doping: An update
BLUM et al. Cholestyramine: an effective, twice-daily dosage regimen
Dyson et al. Two oral beta-adrenergic stimulant drugs, pirbuterol and salbutamol, in reversible airway obstruction
Borra et al. Fatal peritonitis due to group B β-hemolytic streptococcus in a patient receiving chronic ambulatory peritoneal dialysis